Literature DB >> 7065829

Diagnosis and symptoms of depression in opiate addicts. Course and relationship to treatment outcome.

B J Rounsaville, M M Weissman, K Crits-Christoph, C Wilber, H Kleber.   

Abstract

Evaluations of diagnosis and symptoms of depression were undertaken in 157 opiate addicts at entrance to a multimodality drug treatment program and six months later. While 17% were having an episode of major depression (defined by Research Diagnostic Criteria) and 60% had at least mildly elevated depressive symptoms at entrance to treatment, substantial improvement was noted at the six-month reevaluation, with the rates of major depression and elevated symptoms dropping to 12% and 31%, respectively. Symptomatic improvement, although related to retention in treatment, was not the result of specific antidepressant pharmacotherapy and did not differ across treatment modalities. Starting treatment during a major or minor depressive episode was predictive of poorer outcome in the areas of illicit drug use and psychological symptoms, but unrelated to the areas of occupational functioning, legal problems, and program retention.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7065829     DOI: 10.1001/archpsyc.1982.04290020021004

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  46 in total

1.  Physician introduction to opioids for pain among patients with opioid dependence and depressive symptoms.

Authors:  Judith I Tsui; Debra S Herman; Malyna Kettavong; Daniel Alford; Bradley J Anderson; Michael D Stein
Journal:  J Subst Abuse Treat       Date:  2010-08-19

2.  Prevalence of mood and substance use disorders among patients seeking primary care office-based buprenorphine/naloxone treatment.

Authors:  Jonathan D Savant; Declan T Barry; Christopher J Cutter; Michelle T Joy; An Dinh; Richard S Schottenfeld; David A Fiellin
Journal:  Drug Alcohol Depend       Date:  2012-07-06       Impact factor: 4.492

3.  Training in Substance-Related and Addictive Disorders, Part 1: Overview of Clinical Practice and General Recommendations.

Authors:  Gilles Fleury; Robert Milin; David Crockford; Leslie Buckley; Dara Charney; Tony P George; Nady el-Guebaly
Journal:  Can J Psychiatry       Date:  2015-12       Impact factor: 4.356

4.  Psychiatric diagnoses in a sample of HIV-infected people of color in methadone treatment.

Authors:  Mark G Winiarski; Lori I Greene; Alec L Miller; Nancy B Palmer; Jesus Salcedo; Maite Villanueva
Journal:  Community Ment Health J       Date:  2005-08

Review 5.  Quality of life as an outcome of opioid use disorder treatment: A systematic review.

Authors:  Jeremy W Bray; Brandon Aden; Ashley A Eggman; Leah Hellerstein; Eve Wittenberg; Bohdan Nosyk; Judy C Stribling; Bruce R Schackman
Journal:  J Subst Abuse Treat       Date:  2017-02-10

6.  The mental status of 1090 heroin addicts at entry into treatment: should depression be considered a 'dual diagnosis'?

Authors:  Icro Maremmani; Matteo Pacini; Pier Paolo Pani; Giulio Perugi; Joseph Deltito; Hagop Akiskal
Journal:  Ann Gen Psychiatry       Date:  2007-11-13       Impact factor: 3.455

7.  Chronic neuroleptic treatment and mesolimbic dopamine denervation induce behavioural supersensitivity to opiates.

Authors:  L Stinus; M Winnock; A E Kelley
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

8.  Craving predicts opioid use in opioid-dependent patients initiating buprenorphine treatment: a longitudinal study.

Authors:  Judith I Tsui; Bradley J Anderson; David R Strong; Michael D Stein
Journal:  Am J Drug Alcohol Abuse       Date:  2014-02-12       Impact factor: 3.829

9.  Acceptability, validity and reliability of the Structured Clinical Interview for the Spectrum of Substance Use (SCI-SUBS): a pilot study.

Authors:  A Sbrana; L Dell'Osso; C Gonnelli; P Impagnatiello; M R Doria; S Spagnolli; L Ravani; G B Cassano; E Frank; M K Shear; V J Grochocinski; P Rucci; J D Maser; J Endicott
Journal:  Int J Methods Psychiatr Res       Date:  2003       Impact factor: 4.035

10.  Clinical characteristics of treatment-seeking adolescents with opioid versus cannabis/alcohol use disorders.

Authors:  Geetha A Subramaniam; Maxine L Stitzer; George Woody; Marc J Fishman; Ken Kolodner
Journal:  Drug Alcohol Depend       Date:  2008-09-25       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.